Preparing Patients for Treatment: Education, Administration, and Side Effect Management with Amivantamab in EGFR-Mutant NSCLC
Panelists discuss how Julia prepares patients for treatment with amivantamab, including educating them on potential side effects and incorporating proactive strategies into treatment management to optimize patient care and minimize adverse effects.
EP: 1.Overview of EGFR-Mutant Advanced NSCLC
EP: 2.EGFR-Mutant NSCLC Diagnosis: Insights from Patients and Clinicians
EP: 3.Coordinating Care for Patients with Advanced EGFR-Mutant NSCLC: A Multidisciplinary Approach
EP: 4.Multidisciplinary Care of EGFR-Mutant Advanced NSCLC: A Patient Perspective
EP: 5.Tailoring Patient Education and Resources in EGFR-Mutant Advanced NSCLC
EP: 6.Navigating EGFR-Mutant Advanced NSCLC Cancer Treatment: A Patient's Journey
EP: 7.Shared Decision Making in EGFR-Mutant Advanced NSCLC
Now Viewing
EP: 8.Preparing Patients for Treatment: Education, Administration, and Side Effect Management with Amivantamab in EGFR-Mutant NSCLC
Video content above is prompted by the following:
- How do you prepare patients for treatment with amivantamab?
- What side effects do you educate your patients on?
- What proactive strategies do you incorporate into treatment management?
Recent Videos
Related Content
